Ginkgo Bioworks Holdings Gross Profit 2020-2022 | DNA

Ginkgo Bioworks Holdings annual/quarterly gross profit history and growth rate from 2020 to 2022. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Ginkgo Bioworks Holdings gross profit for the quarter ending March 31, 2022 was $0.083B, a 306.79% increase year-over-year.
  • Ginkgo Bioworks Holdings gross profit for the twelve months ending March 31, 2022 was $0.247B, a 672.7% increase year-over-year.
  • Ginkgo Bioworks Holdings annual gross profit for 2021 was $0.184B, a 201.65% increase from 2020.
  • Ginkgo Bioworks Holdings annual gross profit for 2020 was $0.061B, a 12.66% increase from 2019.
  • Ginkgo Bioworks Holdings annual gross profit for 2019 was $0.054B, a INF% increase from .
Ginkgo Bioworks Holdings Annual Gross Profit
(Millions of US $)
2021 $184
2020 $61
2019 $54
Ginkgo Bioworks Holdings Quarterly Gross Profit
(Millions of US $)
2022-03-31 $83
2021-12-31 $108
2021-09-30 $55
2021-06-30
2021-03-31 $20
2020-12-31
2020-09-30 $12
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.223B $0.314B
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $165.407B 10.06
Bio-Rad Laboratories (BIO.B) United States $14.121B 30.63
QIAGEN (QGEN) Netherlands $10.180B 16.07
Biohaven Pharmaceutical Holding (BHVN) United States $10.170B 0.00
Arcus Biosciences (RCUS) United States $1.792B 45.42
Emergent Biosolutions (EBS) United States $1.625B 6.95
Myovant Sciences (MYOV) United Kingdom $1.313B 0.00
Zymeworks (ZYME) Canada $0.365B 0.00
Gelesis Holdings (GLS) United States $0.122B 0.00
Ambrx Biopharma (AMAM) United States $0.110B 0.00
Enzo Biochem (ENZ) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.099B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00